Evidence map›Paper›PMID 35892686›Full record

ArticleBiomedicines2022

Long-Term Persistence of Mitochondrial DNA Instability in HIV-Exposed Uninfected Children during and after Exposure to Antiretroviral Drugs and HIV.

Valérie Desquiret-Dumas, Morgana D'Ottavi, Audrey Monnin, David Goudenège, Nicolas Méda, Amélie Vizeneux, Chipepo Kankasa, Thorkild Tylleskar, Céline Bris, Vincent Procaccio and 4 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Valérie Desquiret-DumasDepartment of Biochemistry and Genetics, University Hospital of Angers, F-49000 Angers, France.
Morgana D'OttaviPathogenesis and Control of Chronic and Emerging Infections, INSERM, Etablissement Français du Sang, University of Montpellier, University of Antilles, F-34394 Montpellier, France.ORCID 0000-0002-6398-6300
Audrey MonninPathogenesis and Control of Chronic and Emerging Infections, INSERM, Etablissement Français du Sang, University of Montpellier, University of Antilles, F-34394 Montpellier, France.
David GoudenègeDepartment of Biochemistry and Genetics, University Hospital of Angers, F-49000 Angers, France.
Nicolas MédaCentre MURAZ, Bobo-Dioulasso 01 B.P. 390, Burkina Faso.
Amélie VizeneuxPathogenesis and Control of Chronic and Emerging Infections, INSERM, Etablissement Français du Sang, University of Montpellier, University of Antilles, F-34394 Montpellier, France.
Chipepo KankasaDepartment of Paediatrics and Child Health, University Teaching Hospital, Lusaka P.O. Box 50001, Zambia.
Thorkild TylleskarCentre for International Health, University of Bergen, N-5020 Bergen, Norway.
Céline BrisDepartment of Biochemistry and Genetics, University Hospital of Angers, F-49000 Angers, France.
Vincent ProcaccioDepartment of Biochemistry and Genetics, University Hospital of Angers, F-49000 Angers, France.ORCID 0000-0002-1537-4684
Nicolas NagotPathogenesis and Control of Chronic and Emerging Infections, INSERM, Etablissement Français du Sang, University of Montpellier, University of Antilles, F-34394 Montpellier, France.
Philippe Van de PerrePathogenesis and Control of Chronic and Emerging Infections, INSERM, Etablissement Français du Sang, University of Montpellier, University of Antilles, F-34394 Montpellier, France.
Pascal ReynierDepartment of Biochemistry and Genetics, University Hospital of Angers, F-49000 Angers, France.ORCID 0000-0003-0802-4608
Jean-Pierre MolèsPathogenesis and Control of Chronic and Emerging Infections, INSERM, Etablissement Français du Sang, University of Montpellier, University of Antilles, F-34394 Montpellier, France.ORCID 0000-0002-6863-6350
Inserm · FRCentre National de la Recherche Scientifique · FRCentre Muraz · BFUniversity of Bergen · NOUniversity Teaching Hospital · ZM

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales ANRS#12274 / ANRS#12341 / ANRS12174-B90European & Developing Countries Clinical Trials Partnership #CT.2006.33020.004The Research Council of Norway GlobVac grant # 183600
6 · The paper itself

Abstract

HIV-exposed uninfected (HEU) children show impaired health outcomes during childhood. A high rate of mitochondrial DNA (mtDNA) instability was reported in the blood of HEU at birth. We aimed to explore the relationship between these health outcomes and mtDNA deletions over time in a case series of 24 HEU children. MtDNA instability was assessed by deep sequencing and analyzed by eKLIPse-v2 algorithm at three time points, namely birth, 1 year, and 6 years of age. Association between mtDNA deletion and health outcomes, including growth, clinical, and neurodevelopmental parameters, were explored using univariate statistical analyses and after stratification with relevant variables. HEU children were selected with an equal male:female ratio. An elevated number of mtDNA deletions and duplications events was observed at 7 days' post-partum. Median heteroplasmy increased at one year of life and then returned to baseline by six years of age. The mtDNA instability was acquired and was not transmitted by the mother. No risk factors were significantly associated with mtDNA instability. In this small case series, we did not detect any association between any health outcome at 6 years and mtDNA instability measures. A significant effect modification of the association between the duration of maternal prophylaxis and child growth was observed after stratification with heteroplasmy rate. Genomic instability persists over time among HEU children but, despite its extension, stays subclinical at six years.

Indexed as

clinical outcomesgenetic alterationsHIVmitochondrianeonatesneurodevelopment

Identifiers

PMID35892686
PMCPMC9331317
OpenAlexW4287838969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.